SEARCH RESULTS FOR:
Katrin Rupalla
CEO, YMMUNOBIO
"Based on our in vivo data for our lead CEACAM1/5 antibody YB-200, we have obtained orphan drug status from FDA for the treatment of liver cancer."
Stefan Randl & Paul Spencer
HEAD OF DRUG SUBSTANCE (SR), HEAD OF DRUG DELIVERY & PRODUCT (PS), EVONIK HEALTH CARE
"The US leads innovation, so if you are not heavily invested there in pharma, you are in trouble. Lots of our clients are shifting their production from Asia, so the US will remain critical to Evonik Health Care’s growth."
Daniel Tellechea
INTERIM CEO, LARGO INC.
"We produce approximately 7% of the global vanadium supply, and on the titanium side, we are expected to produce about two thirds of the Brazilian demand for titanium pigment once the project reaches full capacity."
Eric Smith
MANAGING DIRECTOR, CEMENTATION
"Ontario has one of the highest densities of expertise in underground mining out of any of the jurisdictions we work in."
Marco Prud’Homme
PRESIDENT, NOLINOR AVIATION
"For the next 20 years, there will be lots of exploration and development in a region where there are few roads and limited sea access. So, aviation will play a crucial role in the green transition."
Dustin Angelo
PRESIDENT, CEO AND CO-FOUNDER, NOVAMERA
"There is a huge economic benefit for companies to be able to get that incremental production, because they already have all the infrastructure in place, including people, permits and mills."
Miguel Ángel Arenas
GERENTE GENERAL, GEOTEC
"Nuestro propósito para los próximos años es el uso de la tecnología y la automatización para no exponer a nuestros trabajadores en la línea de fuego y garantizar una operación eficiente y segura a nuestros clientes.”
Ángel Tobar
GERENTE GENERAL, EPIROC REGIÓN ANDINA
"El objetivo de Epiroc es contar con alternativas eléctricas en todos nuestros equipos subterráneos para el 2025 y en los equipos de tajo abierto para el 2030."
Dirk Lorenz-Meyer
CHAIRMAN, BEHN MEYER GROUP
"Our push towards sustainability is the common theme of all investments. We want to create a global network of integrated businesses with multiple synergies."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
MACIG 2025 - Mining in Africa Country Investment Guide
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
